Stocks
Precigen, Inc.PGEN
NASDAQHealthcareBiotechnology$4.17
A clinical-stage biotechnology company developing gene and cell therapies for cancer, autoimmune disorders, and infectious diseases using proprietary gene delivery and control technologies. Its pipeline includes immuno-oncology candidates such as PRGN-2012 and other programs designed to modulate the...
52W Range: $1.23 – $5.47
Congressional Interest in Precigen, Inc. (PGEN)
1 member of Congress has disclosed 1 trade in Precigen, Inc. (PGEN), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading PGEN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-04-01 | Tom Malinowski | buy | $1K – $15K |